Global Total Pharmaceutical Sales by Country

Global Total Pharmaceutical Sales by Country in 2024 gives insight into the pharmaceutical market's size and trends. The United Kingdom ($33.82B) and Canada ($33.7B) lead in sales, followed by Croatia ($27.98B) showing the highest year-on-year variation of 13.16% in 2023. Australia ($12.92B) and Sweden ($6.97B) also reflect notable sales figures with stable growth. Other countries, including Chile ($6.69B), Austria ($5.34B), and Finland ($3.77B), exhibit moderate increases. Smaller markets like Ireland ($3.51B), New Zealand ($1.41B), and Estonia ($0.8105B) are growing but at a slower pace.

Trends to watch:

  • Increasing global emphasis on healthcare access and innovations could drive higher pharmaceutical sales.
  • Technology advancements in drug discovery and precision medicine are expected to continue influencing market growth.
  • Changing regulations and policies in different countries might impact future growth distributions.
  • Emerging markets could play a significant role in diversifying global pharmaceutical sales.

Top countries in Total Pharmaceutical Sales by Country

# 10 Countries Million US Dollars PPP Last Year YoY 5-years CAGR
1 1 United Kingdom 33,820 2023 +2.5% +2.61% View data
2 2 Canada 33,700 2023 +5.78% +5.85% View data
3 3 Croatia 27,980 2023 +10.3% +13.16% View data
4 4 Australia 12,920 2023 +4.01% +4.97% View data
5 5 Sweden 6,970 2023 +4.56% +5.26% View data
6 6 Chile 6,690 2023 +3.85% +2.9% View data
7 7 Austria 5,340 2023 +4.24% +4.91% View data
8 8 Finland 3,770 2023 +4.42% +5.17% View data
9 9 Ireland 3,510 2023 +3.3% +4.19% View data
10 10 New Zealand 1,410 2023 +6.82% +9.42% View data